Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Many employers classify GLP-1 receptor agonists as qualifying medical expenses under their FSA plans, though eligibility depends on your specific plan's coverage rules
EXECUTIVE SUMMARY This brief examines the financialized business model of Novo Nordisk and Eli Lilly for the leading GLP-1 products Ozempic, Rybelsus, and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide)
tirzepatide) Written by: Thomas Kolbe-Booysen , 27 Apr 2026 16 min read Reviewed and fact-checked: Ayesha Bashir , Prescribing Pharmacist, 27 Apr 2026 Mounjaro (tirzepatide) and Wegovy (semaglutide) are weekly weight loss injections that can help you reach a healthier weight
We also accept various payment methods and can discuss financing options during your consultation to find what works best for your situation.
Reading technique that prevents errors Hold the syringe at eye level with the tip pointing up
One such exception is when the drug is not commercially available, such that it appears on the FDA drug shortage list under Section 506E of the FD&C Act
US$ 22.98
US$ 24.88
US$ 22.79
